IP Library Granted Patent US 8,425,493
Granted Patent B2
US 8,425,493 · App. 10/515,152 · Granted Apr 23, 2013

Implantable medication delivery device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,425,493
App. No.
10/515,152
Granted
Apr 23, 2013
Kind
B2
Abstract

An implantable medication delivery device that is highly space efficient and can reliably and safely deliver controlled medication doses to a target site. The system includes a variable volume medication reservoir that is exposed to an ambient pressure equal to the ambient pressure at a system outlet port. A pump/valve subassembly is provided to draw medication from the reservoir and force a medication dose along a fluid transfer passageway to the outlet port. The pump/valve subassembly incorporates a safety mechanism, e.g., a balanced valve, which normally blocks medication flow to the outlet port and opens only in response to a pump induced unbalancing force. A protective shell is also disclosed for protecting the ambient reservoir.

Claims (32)

1. An integrated medication delivery device configured to be implanted into a patient's body, said device comprising:

a mounting structure;

a movable wall carried by said mounting structure and defining a variable volume reservoir;

a fill port for supplying medication to said reservoir;

said mounting structure defining a fluid inlet port communicating with said reservoir, a fluid outlet port for discharging medication into said body, and a fluid path operable to transfer medication from said inlet port to said outlet port;

said fluid path including a pump chamber, an inlet check valve that is biased to the closed state, that opens when pressure in the pump chamber is lower than reservoir pressure and located between said inlet port and said pump chamber, an outlet check valve that is biased to the closed state, that opens when pressure in the pump chamber is greater than reservoir pressure and located between said pump chamber and said outlet port, and a safety valve that is located between said outlet valve and said outlet port and is exposed to reservoir pressure by way of a channel that is not part of the fluid path;

a pump actuator associated with said pump chamber operable to define a suction mode for pulling fluid via said inlet port from said reservoir into said pump chamber and a pressure mode that causes fluid from said pump chamber to be forced through the outlet check valve to said safety valve; and wherein

said safety valve permits fluid flow when the pressure in said pump chamber exceeds the pressure in said reservoir and prevents fluid flow when the pressure in said reservoir exceeds the pressure in said pump chamber to prevent unintended medication discharge through said outlet port.

2. The device of claim 1 configured so that when implanted in a patient's body, both said movable wall and said outlet port are exposed to ambient pressure; and wherein

said safety valve permits fluid flow during said pressure mode when said pump actuator acts to increase pressure in said pump chamber.

3. The device of claim 1 wherein said movable wall is comprised of a flexible non extensible non porous material.

4. The device of claim 1 wherein

said inlet check valve is biased to the closed state by a spring; and

said outlet check valve is biased to the closed state by a spring.

5. The device of claim 1 wherein said safety valve includes a valve element movable between open and closed positions and including means biasing said valve element to said closed position to normally prevent fluid flow to said outlet port; and

means for moving said safety valve element to said open position when said pump actuator increases pressure in said pump chamber.

6. The device of claim 5 including means responsive to an increase in pressure in said reservoir for increasing the sealing pressure on said safety valve element to prevent fluid flow to said outlet port.

7. The device of claim 1 wherein said mounting structure comprises a substantially planar structure.

8. The device of claim 1 wherein said fluid inlet port is located within said reservoir.

9. The device of claim 8 wherein

said mounting structure defines a safety valve port located within said reservoir and in spaced relation to said fluid inlet port; and

said safety valve port is in fluid communication with said safety valve by way of said channel.

10. The device of claim 9 wherein

said safety valve defines an open state that permits fluid flow and a closes state that prevents fluid flow; and

said safety valve is self-biased to the closed state.

11. The device of claim 9 wherein said mounting structure defines a first side and a second side opposite said first side, and said movable wall is carried by said first side of said mounting structure, said device further comprising

a cover secured to said second side of said mounting structure such that an internal compartment, in which said pump actuator is located, is defined therebetween.

12. The device of claim 9 wherein

said mounting structure includes first and second plates secured to one another;

said fluid inlet port and said safety valve port each extend though said first plate;

at least a portion of said outlet port is associated with said first plate; and

said pump actuator is associated with said second

Assignments (11)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
RELEASE OF SECURITY INTEREST Recorded Jul 14, 2025
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 071698/0639 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2021
From: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDTRONIC MINIMED, INC.
Reel/Frame 057962/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 13, 2019
From: MEDALLION THERAPEUTICS, INC.
To: THE ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 051287/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2014
From: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
To: MEDALLION THERAPEUTICS, INC.
Reel/Frame 032892/0067 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SCHEDULE WHICH REFLECTED PATENT NUMBER AS 8,327,041 AND SHOULD HAVE BEEN REFLECTED AS 8,372,041. PREVIOUSLY RECORDED ON REEL 032815 FRAME 0188. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded May 6, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032827/0478 →
SECURITY INTEREST Recorded May 2, 2014
From: MEDALLION THERAPEUTICS, INC.
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 032815/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2010
From: INFUSION SYSTEMS, LLC
To: ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH
Reel/Frame 025429/0383 →
CHANGE OF NAME Recorded Apr 14, 2008
From: ADVANCED BIONICS CORPORATION
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 020796/0264 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2008
From: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
To: INFUSION SYSTEMS, LLC
Reel/Frame 020329/0853 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2006
From: NASON, CLYDE K.; DAS, STEPHEN D.; LORD, PETER C.; YAP, DARREN Y.K.; LEBEL, RONALD J.
To: ADVANCED BIONICS CORPORATION
Reel/Frame 018392/0866 →